106 related articles for article (PubMed ID: 18165179)
1. Interleukin-6 is not essential for bone turnover in hypothyroid mice.
Mysliwiec J; Zbucki R; Winnicka M; Sawicki B; Nikolajuk A; Kaminski K; Mysliwiec P; Musial W; Bondyra Z; Walecki J; Gorska M
Folia Histochem Cytobiol; 2007; 45(4):387-92. PubMed ID: 18165179
[TBL] [Abstract][Full Text] [Related]
2. A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice.
Mysliwiec J; Zbucki R; Winnicka MM; Sawicki B; Nikolajuk A; Kaminski K; Mysliwiec P; Musial W; Bondyra Z; Walecki J; Gorska M
Horm Metab Res; 2007 Dec; 39(12):884-8. PubMed ID: 17973207
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-6 on RANKL-RANK/osteoprotegerin system in hypothyroid ovariectomized mice.
Mysliwiec J; Zbucki R; Nikolajuk A; Mysliwiec P; Taranta A; Kaminski K; Bondyra Z; Dadan J; Gorska M; Winnicka MM
Folia Histochem Cytobiol; 2010 Dec; 48(4):549-54. PubMed ID: 21478097
[TBL] [Abstract][Full Text] [Related]
4. Estrogens modulate RANKL-RANK/osteoprotegerin mediated interleukin-6 effect on thyrotoxicosis-related bone turnover in mice.
Mysliwiec J; Zbucki R; Nikolajuk A; Mysliwiec P; Kaminski K; Bondyra Z; Dadan J; Gorska M; Winnicka MM
Horm Metab Res; 2011 Apr; 43(4):236-40. PubMed ID: 21332025
[TBL] [Abstract][Full Text] [Related]
5. RANKL/Osteoprotegerin System and Bone Turnover in Hashimoto Thyroiditis.
Konca Degertekin C; Turhan Iyidir O; Aktas Yılmaz B; Elbeg S; Pasaoglu OT; Pasaoglu H; Cakır N; Arslan M
Calcif Tissue Int; 2016 Oct; 99(4):365-72. PubMed ID: 27328677
[TBL] [Abstract][Full Text] [Related]
6. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
7. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and its considerable role in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in postmenopausal women.
Mysliwiec J; Adamczyk M; Nikolajuk A; Gorska M
Endokrynol Pol; 2011; 62(4):299-302. PubMed ID: 21879468
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
11. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
12. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Penttilä IM; Rauramaa R
Bone; 2004 Aug; 35(2):439-47. PubMed ID: 15268895
[TBL] [Abstract][Full Text] [Related]
13. A change of osteocalcin (OC) and tartrate resistant acid phosphatase 5b (TRACP-5b) with the menstrual cycle.
Lee S; Kumagai T; Hashimoto J; Satoh A; Suzuki T; Yamai K; Ohta S
Horm Metab Res; 2012 Sep; 44(9):699-703. PubMed ID: 22517558
[TBL] [Abstract][Full Text] [Related]
14. High force eccentric exercise enhances serum tartrate-resistant acid phosphatase-5b and osteocalcin.
Tsuchiya Y; Sakuraba K; Ochi E
J Musculoskelet Neuronal Interact; 2014 Mar; 14(1):50-7. PubMed ID: 24583540
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
16. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
17. [New approved markers of bone turnover for osteoporosis in Japan].
Miki T; Masaki H
Clin Calcium; 2012 Jun; 22(6):877-83. PubMed ID: 22653028
[TBL] [Abstract][Full Text] [Related]
18. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
19. Does methamphetamine affect bone metabolism?
Tomita M; Katsuyama H; Watanabe Y; Okuyama T; Fushimi S; Ishikawa T; Nata M; Miyamoto O
Toxicology; 2014 May; 319():63-8. PubMed ID: 24582730
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
